Showing results (131-140 of 622) with videos related to
Sort By:
Pageof 63
Heart (British Cardiac Society)|May 24, 2006
Metabolic syndrome and risk for heart failure in middle-aged menE Ingelsson, J Arnlöv, L Lind, et al.European Heart Journal|December 1, 1996
Left ventricular hypertrophy and geometry in a population sample of elderly malesB Andrén, L Lind, G Hedenstierna, et al.Scandinavian Journal of Urology and Nephrology|January 1, 1991
Reduction in serum alkaline phosphatase levels by treatment with active vitamin D (alphacalcidol) in primary and secondary hyperparathyroidism and in euparathyroid individualsL Lind, B Wengle, H Lithell, et al.Upsala Journal of Medical Sciences|January 1, 1991
Potassium and blood pressureL Lind, H Lithell, T Pollare, et al.Blood Pressure|June 16, 2000
Blood pressure changes in relation to sodium and calcium status in induced hyperinsulinemiaA Haenni, L Lind, R Reneland, et al.American Heart Journal|December 1, 1994
Long-term metabolic effects of antihypertensive drugsL Lind, T Pollare, C Berne, et al.Preventive Medicine Reports|November 11, 2025
Trends in influenza vaccine disparities in the U.S. following the introduction of COVID-19: Insights from the national health interview surveyMargaret L Lind, Emily Goldmann, Gregory S LalondeJournal of Internal Medicine|January 30, 2004
A new Q/QS pattern on the resting electrocardiogram is associated with impaired insulin secretion and a poor prognosis in elderly men independently of history of myocardial infarctionK Dunder, L Lind, B Zethelius, et al.Journal of Human Hypertension|February 1, 1992
Metabolic cardiovascular risk factors and the renin-aldosterone system in essential hypertensionL Lind, H Lithell, L Wide, et al.Journal of Internal Medicine|April 1, 1992
Plasma ionized calcium and cardiovascular risk factors in mild primary hyperparathyroidism: effects of long-term treatment with active vitamin D (alphacalcidol)L Lind, B Wengle, H Lithell, et al.Pageof 63